Skip to main content

and
  1. Article

    Open Access

    Neoadjuvant chemotherapy alters the balance of effector to suppressor immune cells in advanced ovarian cancer

    At diagnosis, tumor-infiltrating lymphocytes (TILs) are prognostic in epithelial ovarian cancer (EOC). We recently demonstrated that neoadjuvant chemotherapy (NACT) significantly increased stromal TILs. Here,...

    Alexandra Leary, Catherine Genestie, Félix Blanc-Durand in Cancer Immunology, Immunotherapy (2021)

  2. No Access

    Article

    Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens

    HER2-negative metastatic breast cancer (MBC) is a common setting in which chemotherapy could be effective even in later lines of treatment. Oral etoposide has demonstrated clinical activity in this setting in ...

    Luc Cabel, Matthieu Carton, Bianca Cheaib in Breast Cancer Research and Treatment (2019)

  3. Article

    Open Access

    The PI3K/Akt/mTOR pathway in ovarian cancer: therapeutic opportunities and challenges

    The phosphatidylinositol 3 kinase (PI3K) pathway is frequently altered in cancer, including ovarian cancer (OC). Unfortunately, despite a sound biological rationale and encouraging activity in preclinical mode...

    Bianca Cheaib, Aurélie Auguste, Alexandra Leary in Chinese Journal of Cancer (2015)